NWRD06 DNA Plasmid for HCC After Curative Resection.

Clinical trial NCT07324304 · RECRUITING

Trial details

NCT number: NCT07324304
Sponsor: Newish Technology (Beijing) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2025-12-08
Primary completion: 2028-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.